{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:41:41Z","timestamp":1774946501269,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/S\/14\/1\/501291"],"award-info":[{"award-number":["IA\/S\/14\/1\/501291"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.01753","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T03:35:06Z","timestamp":1533008106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Position Paper on Road Map for RNA Virus Research in India"],"prefix":"10.3389","volume":"9","author":[{"given":"Guruprasad R.","family":"Medigeshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra R.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1080\/21645515.2017.1318236","article-title":"Safety and immunogenicity of Bio Pox, a live varicella vaccine (Oka strain) in Indian children: a comparative multicentric, randomized phase II\/III clinical trial","volume":"13","author":"Dubey","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1006215","DOI":"10.1371\/journal.ppat.1006215","article-title":"Comparative analysis estimates the relative frequencies of co-divergence and cross-species transmission within viral families","volume":"13","author":"Geoghegan","year":"2017","journal-title":"PLoS Pathog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.12688\/wellcomeopenres.12256.1","article-title":"A framework for controlled human infection model (chim) studies in malawi: report of a wellcome trust workshop on CHIM in low income countries held in Blantyre, Malawi","volume":"2","author":"Gordon","year":"2017","journal-title":"Wellcome Open Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2221-1691(15)30366-X","article-title":"The past, current and future trends in DNA vaccine immunisations","volume":"5","author":"Hasson","year":"2015","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/14760584.2017.1294068","article-title":"Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd","volume":"16","author":"Kulkarni","year":"","journal-title":"Expert Rev. Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1128\/mBio.02284-17","article-title":"Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus","volume":"9","author":"Park","year":"2018","journal-title":"MBio"},{"key":"B13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1473-3099(12)70292-X","article-title":"Human microbial challenge: the ultimate animal model","volume":"12","author":"Pollard","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0006191","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3390\/vaccines6020020","article-title":"New kids on the block: RNA-based influenza virus vaccines","volume":"6","author":"Scorza","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.4269\/ajtmh.14-0002","article-title":"Economic and disease burden of dengue illness in India","volume":"91","author":"Shepard","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/infdis\/jiv023","article-title":"A japanese encephalitis vaccine from india induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains","volume":"212","author":"Singh","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","article-title":"The global burden of dengue: an analysis from the Global Burden of Disease Study 2013","volume":"16","author":"Stanaway","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41541-017-0036-2","article-title":"Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines","volume":"2","author":"Sutton","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fmicb.2017.01372","article-title":"Complexity of human antibody response to dengue virus: implication for vaccine development","volume":"8","author":"Tsai","year":"2017","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"Vignuzzi","year":"2005","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aam7120","article-title":"A single mutation in the prM protein of Zika virus contributes to fetal microcephaly","volume":"358","author":"Yuan","year":"2017","journal-title":"Science"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T03:35:08Z","timestamp":1533008108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":24,"alternative-id":["10.3389\/fmicb.2018.01753"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.01753","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"article-number":"1753"}}